Zacks: Analysts Anticipate Safeguard Scientifics, Inc. (SFE) to Announce -$1.11 EPS
Wall Street analysts expect Safeguard Scientifics, Inc. (NYSE:SFE) to report earnings of ($1.11) per share for the current quarter, according to Zacks Investment Research. Zero analysts have made estimates for Safeguard Scientifics’ earnings. Safeguard Scientifics reported earnings of ($1.18) per share in the same quarter last year, which indicates a positive year over year growth rate of 5.9%. The business is expected to report its next quarterly earnings results on Thursday, October 26th.
On average, analysts expect that Safeguard Scientifics will report full year earnings of ($4.69) per share for the current fiscal year. For the next fiscal year, analysts forecast that the company will report earnings of ($4.30) per share. Zacks Investment Research’s EPS calculations are a mean average based on a survey of sell-side research analysts that follow Safeguard Scientifics.
Safeguard Scientifics (NYSE:SFE) last released its quarterly earnings results on Thursday, July 27th. The asset manager reported ($1.43) EPS for the quarter, missing the Zacks’ consensus estimate of ($1.11) by $0.32. During the same period in the prior year, the business earned $1.92 earnings per share.
Several brokerages recently commented on SFE. Zacks Investment Research lowered Safeguard Scientifics from a “hold” rating to a “strong sell” rating in a research report on Saturday, June 24th. BidaskClub upgraded Safeguard Scientifics from a “hold” rating to a “buy” rating in a research report on Thursday, July 13th. Finally, ValuEngine upgraded Safeguard Scientifics from a “strong sell” rating to a “sell” rating in a research report on Friday, June 2nd.
Safeguard Scientifics (NYSE SFE) traded down 1.67% during midday trading on Tuesday, hitting $11.75. The stock had a trading volume of 48,141 shares. Safeguard Scientifics has a 52 week low of $10.60 and a 52 week high of $14.34. The stock’s market capitalization is $239.85 million. The company’s 50 day moving average price is $12.04 and its 200-day moving average price is $12.07.
A number of hedge funds and other institutional investors have recently bought and sold shares of SFE. KBC Group NV increased its position in Safeguard Scientifics by 47.5% in the first quarter. KBC Group NV now owns 9,447 shares of the asset manager’s stock worth $120,000 after buying an additional 3,044 shares during the period. American International Group Inc. increased its position in Safeguard Scientifics by 7.2% in the first quarter. American International Group Inc. now owns 12,407 shares of the asset manager’s stock worth $158,000 after buying an additional 833 shares during the period. Nationwide Fund Advisors increased its position in Safeguard Scientifics by 7.6% in the second quarter. Nationwide Fund Advisors now owns 14,195 shares of the asset manager’s stock worth $169,000 after buying an additional 1,006 shares during the period. Alliancebernstein L.P. increased its position in Safeguard Scientifics by 27.4% in the second quarter. Alliancebernstein L.P. now owns 14,430 shares of the asset manager’s stock worth $172,000 after buying an additional 3,100 shares during the period. Finally, Goldman Sachs Group Inc. increased its position in Safeguard Scientifics by 12.9% in the first quarter. Goldman Sachs Group Inc. now owns 15,336 shares of the asset manager’s stock worth $195,000 after buying an additional 1,754 shares during the period. 75.31% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: This piece of content was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/08/16/zacks-analysts-anticipate-safeguard-scientifics-inc-sfe-to-announce-1-11-eps.html.
Safeguard Scientifics Company Profile
Safeguard Scientifics, Inc is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Stock Ratings for Safeguard Scientifics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics Inc. and related stocks with our FREE daily email newsletter.